Mounjaro 10mg Injection – Tirzepatide 10mg

$250

6 products sold in last 4 hours

Selling fast! Over 10 people have in their cart

Mounjaro 10mg Injection contains tirzepatide 10mg, a once-weekly injectable medicine that activates both GIP and GLP-1 receptors. It is used under medical supervision to improve blood glucose control in adults with type 2 diabetes and can also reduce appetite and food intake, supporting weight reduction.

29 people are viewing this right now

Estimated Delivery : Up to 4 business days
Free Shipping & Returns : On all orders over $200

Guaranteed Safe And Secure Checkout

Description
Reviews(0)

Mounjaro 10mg Injection contains tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is administered once weekly by subcutaneous injection.

Tirzepatide works through two complementary incretin pathways. It enhances glucose-dependent insulin secretion, reduces glucagon secretion, slows gastric emptying, and influences appetite and food intake. These effects can help improve blood glucose control and may contribute to weight reduction.

The 10mg strength is a higher maintenance-dose option reached after gradual dose escalation through lower strengths when tolerated. Dose increases should only be made according to the prescribing healthcare professional’s instructions.

Prescription Required.

Product Information


Product Information	Details
Brand Name	Mounjaro
Active Ingredient	Tirzepatide
Strength	10mg
Dosage Form	Injection
Drug Class	GIP/GLP-1 Receptor Agonist
Route	Subcutaneous
Frequency	Once weekly
Primary Use	Type 2 Diabetes Management
Prescription	Required

How It Works

Tirzepatide activates GIP and GLP-1 receptors, helping increase glucose-dependent insulin secretion, decrease glucagon secretion, slow gastric emptying, and regulate appetite and food intake.

Administration

Mounjaro 10mg is administered once weekly by subcutaneous injection, generally into the abdomen, thigh, or upper arm. It can be administered with or without food.

Rotate injection sites and follow the prescribed dose-escalation schedule. Do not increase the dose without medical supervision.

Common Side Effects

Important Safety Information

Important risks include pancreatitis, gallbladder disease, dehydration and kidney problems, hypoglycemia when used with insulin or insulin secretagogues, and serious hypersensitivity reactions.

Mounjaro should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Tell your healthcare professional about all medicines you take, particularly insulin or sulfonylureas.

Storage

Store according to the manufacturer’s instructions. Keep refrigerated and protect from light. Do not freeze. Follow the product packaging and prescribing information for exact storage requirements.